These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Progestins in the menopause in healthy women and breast cancer patients. Pasqualini JR. Maturitas; 2009 Apr 20; 62(4):343-8. PubMed ID: 19179024 [Abstract] [Full Text] [Related]
9. Pharmacology of different progestogens: the special case of drospirenone. Sitruk-Ware R. Climacteric; 2005 Oct 20; 8 Suppl 3():4-12. PubMed ID: 16203650 [Abstract] [Full Text] [Related]
10. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. L'hermite M, Simoncini T, Fuller S, Genazzani AR. Maturitas; 2008 Oct 20; 60(3-4):185-201. PubMed ID: 18775609 [Abstract] [Full Text] [Related]
11. [Pharmacology of progestins]. Michel G, Kuttenn F. Rev Prat; 1981 Apr 01; 31(19):1333-47. PubMed ID: 7233015 [Abstract] [Full Text] [Related]
12. Progesterone, progestogens and psychosomatic health of the climacteric woman. Bitzer J. Maturitas; 2009 Apr 20; 62(4):330-3. PubMed ID: 19091497 [Abstract] [Full Text] [Related]
15. Selective effect of chlormadinone acetate on brain allopregnanolone and opioids content. Pluchino N, Lenzi E, Merlini S, Giannini A, Cubeddu A, Casarosa E, Begliuomini S, Luisi M, Cela V, Genazzani AR. Contraception; 2009 Jul 20; 80(1):53-62. PubMed ID: 19501216 [Abstract] [Full Text] [Related]
16. Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved. Nilsen J, Deng J, Brinton RD. Drug News Perspect; 2005 Nov 20; 18(9):545-53. PubMed ID: 16421627 [Abstract] [Full Text] [Related]
18. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, Akwa Y, Rajkowski K, Baulieu EE. Endocr Rev; 2007 Jun 20; 28(4):387-439. PubMed ID: 17431228 [Abstract] [Full Text] [Related]